×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Carcinoma, Human
0.510
Biomarker
CTD_human
p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression.
30381462 2018
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Carcinoma, Human
0.510
Biomarker
CTD_human
Genomic landscape of cutaneous T cell lymphoma.
26192916 2015
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Carcinoma, Human
0.510
Biomarker
CTD_human
The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
26229107 2015
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Carcinoma, Human
0.510
Biomarker
CTD_human
Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.
17388661 2007
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Carcinoma, Human
0.510
Biomarker
CTD_human
Evaluation of the prognostic and predictive value of p53 and Bcl-2 in breast cancer patients participating in a randomized study with dose-dense sequential adjuvant chemotherapy.
16968874 2006
×
Entrez Id: 7157
Gene Symbol: TP53
TP53
Mammary Carcinoma, Human
0.510
Biomarker
CTD_human
Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF.
15802278 2005
×
Entrez Id: 4312
Gene Symbol: MMP1
MMP1
Mammary Carcinoma, Human
0.500
Biomarker
CTD_human
Matrix metalloproteinase Mmp-1a is dispensable for normal growth and fertility in mice and promotes lung cancer progression by modulating inflammatory responses.
23548910 2013
×
Entrez Id: 167465
Gene Symbol: ZNF366
ZNF366
Mammary Carcinoma, Human
0.500
Biomarker
CTD_human
DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
20008677 2010
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
26124351 2015
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.
26124351 2015
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models.
25221644 2014
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Molecular profiling of single circulating tumor cells with diagnostic intention.
25358515 2014
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models.
25221644 2014
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Molecular profiling of single circulating tumor cells with diagnostic intention.
25358515 2014
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.
21638049 2012
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.
22302033 2012
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy.
22302033 2012
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.
21638049 2012
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Suppression of Heregulin-β1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation.
19617202 2011
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Suppression of Heregulin-β1/HER2-Modulated Invasive and Aggressive Phenotype of Breast Carcinoma by Pterostilbene via Inhibition of Matrix Metalloproteinase-9, p38 Kinase Cascade and Akt Activation.
19617202 2011
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
21501481 2011
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
20941507 2011
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.
21501481 2011
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Therapeutic
CTD_human
Immunophenotypic predictive profiling of BRCA1-associated breast cancer.
20941507 2011
×
Entrez Id: 2064
Gene Symbol: ERBB2
ERBB2
Mammary Carcinoma, Human
0.370
Biomarker
CTD_human
Selective death of human breast cancer cells by lytic immunoliposomes: Correlation with their HER2 expression level.
19896266 2010